Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine for Glycemic Control in Diabetes
NCT01226537Phase 2Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of taurine in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Hamad Medical Corporation. Primary endpoints: Fasting glucose at 9 months, Glycated Hemoglobin at 9 months and 5 more. Status: unknown.
02
Drugs
taurine
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01226537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226537.